BMY Sentiment Analysis
We collect and analyze sentiment surrounding BMY stock to help you make informed investment decisions.
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 9.78% Profit Margin
Published on March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY has reached the price target forecasted by QuantWave with a profitable outcome of 9.78%....
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.11% Profit - QuantWave
Published on March 10, 2025
QuantWave, the automated forecasting platform, successfully predicted the price movement of BRISTOL-MYERS SQUIBB COMPANY, with the forecast signal date of 2024-11-12 indicating a long position at a price of 57.75 $. The target price of 62.43 $ was re...
BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Price Target with 9.58% Profit Gain
Published on March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY, a leading pharmaceutical company, recently achieved its forecast price target as predicted by QuantWave's automated forecasting platform. The forecast signal was generated on November 19, 2024, when the stock was trading...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.63% Profit
Published on March 10, 2025
On November 26, 2024, QuantWave's forecast for BRISTOL-MYERS SQUIBB COMPANY indicated a long position with the stock price at $57....
QuantWave Achieves 8.63% Profit Forecast for Bristol-Myers Squibb Company
Published on March 10, 2025
QuantWave, the automated forecasting platform, successfully hit its price target forecast for BRISTOL-MYERS SQUIBB COMPANY, with a profit of 8.63%. The forecast signal date of November 26, 2024, indicated a long position on the stock when it was pric...
BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Target with 8.11% Profit: A Success Story for QuantWave
Published on March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY (Ticker: BMY) recently reached its forecast target as predicted by QuantWave, resulting in an impressive profit of 8.11%. The forecast signal was issued on November 12, 2024, indicating a long position with the stock trad...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target, Generating 9.58% Profit - QuantWave Analysis
Published on March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY has successfully reached the price target forecasted by QuantWave, resulting in a profitable long position for investors. The forecast signal was given on November 19, 2024, with a price of 56.24$. The predicted direction...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 9.78% Profit: A Success Story for QuantWave
Published on March 10, 2025
BRISTOL-MYERS SQUIBB COMPANY's stock has recently achieved the price target forecast set by QuantWave, resulting in a profit of 9.78%. The forecast signal was initiated on December 10, 2024, with the stock priced at $56.13 and a predicted direction o...
BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.24% Profit
Published on March 7, 2025
On February 18, 2025, QuantWave, an automated forecasting platform, issued a long forecast signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $53.15. This prediction came to fruition on March 7, 2025, as the stock soared to $59.65,...
BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 10.56% Profit: QuantWave Forecast Success
Published on March 6, 2025
BRISTOL-MYERS SQUIBB COMPANY stock recently reached the price target forecast set by QuantWave, resulting in a profit of 10....
Positive News Drives Bristol-Myers Squibb Co BMY Stock Up
Published on February 27, 2025
Bristol-Myers Squibb Co (BMY) experienced a surge in stock value on Monday due to positive news surrounding the company....
Bristol-Myers Squibb Continues to Thrive in Oncology Field
Published on February 25, 2025
Bristol-Myers Squibb, a renowned pharmaceutical company, is garnering attention for its remarkable success in the field of oncology. The company's stock, listed on NYSE as BMY, has been identified as a strong buy due to its consistent growth and prom...
Bristol-Myers Squibb Continues to Drive Revenue Growth with Top Products
Published on February 20, 2025
BMY Briston-Myers Squibb Company, a renowned pharmaceutical giant, is set to achieve impressive revenue growth in the coming years. According to Statista, Briston-Myers Squibb's top products are projected to generate substantial revenue from 2022 to ...
Bristol-Myers Squibb Company Reports Strong Earnings and Promising Growth Outlook
Published on February 16, 2025
Bristol-Myers Squibb Company (BMY) has recently reported strong earnings and a positive growth outlook for the future....
Bristol-Myers Squibb Company BMY Set to Report Strong Earnings, Stocks Prognosis Recommends Buying
Published on February 15, 2025
Bristol-Myers Squibb Company (BMY) is expected to report impressive earnings for the quarter, according to Stocks Prognosis....
Bristol-Myers Squibb Company BMY Shows Promising Outlook for 2025
Published on February 14, 2025
Bristol-Myers Squibb Company (BMY) has recently reported its earnings and showcased an impressive performance....
BRISTOL-MYERS SQUIBB COMPANY Stock Hits Forecasted Short Price Target with Profit of 8.86%
Published on February 14, 2025
On January 23, 2025, QuantWave issued a forecast signal for BRISTOL-MYERS SQUIBB COMPANY's stock, predicting a short direction with a price of 58.51 $. This forecast reached its target on February 14, 2025, with the stock price hitting 53.32 $, resul...
QuantWave Successfully Predicts 8.86% Profit in Bristol-Myers Squibb Company Stock
Published on February 14, 2025
QuantWave, an automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with the successful achievement of a price target forecast for Bristol-Myers Squibb Company. The forecast, which signaled a short dire...
Bristol Myers Squibb Announces $2 Billion Cost Reduction Plan by 2027
Published on February 13, 2025
Bristol Myers Squibb (BMY), a leading global biopharmaceutical company, has unveiled a strategic plan to achieve $2 billion in cost savings by 2027. The company aims to optimize its operations and streamline its business processes to enhance efficien...
Bristol Myers Squibb BMY reports strong earnings in Q4 2024, despite challenges in the industry
Published on February 12, 2025
Bristol Myers Squibb, a leading pharmaceutical company, has announced its earnings for the fourth quarter of 2024....
The Unstoppable Rise of BMY Bristol-Myers Squibb Company
Published on February 8, 2025
Bristol-Myers Squibb Company (BMY) has once again demonstrated its resilience and innovation with a remarkable Q4 2024 performance....
Is Bristol-Myers Squibb Company BMY the Safe Stock to Buy for the Long Term in 20
Published on February 4, 2025
The pharmaceutical giant Bristol-Myers Squibb Company (BMY) continues to be considered as one of the best long term low risk stocks to invest in, according to financial experts. With a strong track record of delivering consistent returns and a robust...
Why Bristol-Myers Squibb Company BMY Is The Top Choice For Blue Chip Investors
Published on February 2, 2025
Bristol-Myers Squibb Company (BMY) has solidified its position as the leading blue chip stock to buy under $100....
Investors Heavily Search Bristol Myers Squibb Company BMY: Here is What You Need to Know
Published on January 31, 2025
According to recent reports, Bristol-Myers Squibb Company (NYSE: BMY) has caught the attention of investors, with institutional ownership reaching a staggering 77%. This indicates that major investors have a significant stake in the company and belie...
Investors Look to Bristol Myers Squibb Company for Promising Profit Projections
Published on January 29, 2025
As institutional investors heavily search for lucrative investment opportunities, many are turning their attention to Bristol Myers Squibb Company (BMY). Boasting a substantial 77% ownership by institutional investors, BMY has become a focal point fo...